Showing results (11-20 of 246) with videos related to
Sort By:
Pageof 25
Contraception|May 1, 1993
Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancerD V Spicer, M C Pike, A Pike, et al.Ernst Schering Foundation Symposium Proceedings|June 11, 2008
Estrogens, progestins, and risk of breast cancerM C Pike, A H Wu, D V Spicer, et al.Journal of the National Cancer Institute|March 16, 1994
Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer riskD V Spicer, G Ursin, Y R Parisky, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
The detection of changes in mammographic densitiesG Ursin, M A Astrahan, M Salane, et al.Cancer Detection and Prevention|January 1, 1990
Reducing cancer risk in women through lifestyle-mediated changes in hormone levelsM C PikeJournal of Chronic Diseases|January 1, 1987
Age-related factors in cancers of the breast, ovary, and endometriumM C PikeSelective Cancer Therapeutics|January 1, 1991
Tolerance of extended (28 day) continuous infusion of 5-fluorouracil in advanced head and neck cancerS M Grunberg, C Clay, D V SpicerSeminars in Oncology|April 1, 1995
Oral vinorelbine (Navelbine) in the treatment of advanced breast cancerE P Winer, L Chu, D V SpicerScience (New York, N.Y.)|April 23, 1976
An inhibitor of macrophage chemotaxis produced by neoplasmsR Snyderman, M C PikePediatric Clinics of North America|May 1, 1977
Disorders of leukocyte chemotaxisR Snyderman, M C PikePageof 25